Carcinogenesis Advance Access originally published online on April 28, 2005
Carcinogenesis 2005 26(9):1649; doi:10.1093/carcin/bgi108
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.26 no.9 © Oxford University Press 2005; all rights reserved.
LETTER TO THE EDITOR |
A bias in genotyping the ERBB2 (HER2) Ile655Val variant
1 Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany and 2 Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden
* To whom correspondence should be addressed Email: b.frank@dkfz.de
| The first 10% of the full text of this article appears below. |
Dear Sir,
As part of association studies on cancer risk ERBB2 Ile655Val is a frequently analysed polymorphism. Recent publications have analysed the association of the common ERBB2 single nucleotide polymorphism (SNP) Ile655Val with breast cancer risk using TaqMan
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. R. Benusiglio, C. Luccarini, O. Ajai, B. A.J. Ponder, and P. D. Pharoah Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant Carcinogenesis, December 1, 2005; 26(12): 2213 - 2213. [Full Text] [PDF] |
||||
